Early myocardial dysfunction in the diabetic heart: Current research and clinical applications

被引:32
作者
Scognamiglio, R [1 ]
Avogaro, A [1 ]
Negut, C [1 ]
Piccolotto, R [1 ]
de Kreutzenberg, SV [1 ]
Tiengo, A [1 ]
机构
[1] Univ Padua, Dept Clin & Expt Med, Div Metab Dis, Giustinianeo Hosp,Metab Cardiol Unit, Padua, Italy
关键词
D O I
10.1016/j.amjcard.2003.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with diabetes mellitus have a high incidence of heart failure, which contributes significantly to their increased cardiovascular morbidity and mortality. One of the major complications of diabetes is the development of cardiomyopathy, a condition characterized by defects of contractile function in the absence of significant coronary artery disease or systemic hypertension. Experimental data in animal models show that contractile depression begins as early as 1 week after induction of diabetes, and the dysfunction is related to an isomyosin distribution shift from V-1 with high adenosine triphosphatase (ATPase) to V-3 with low ATPase activity. Moreover, diabetes is associated with an increased or poorly regulated rate of amino acid catabolism at the cardiac level. Abnormal responses to acute left ventricular (LV) overload induced by exercise (isometric or isotonic) have been demonstrated in patients with diabetes. Impaired augmentation of LV ejection fraction occurs in up to 40% of patients with diabetes. Analysis of the LV afterload-pump function (LV circumferential wall stress-ejection fraction) relationship shows that defective contractile recruitment is the main cause of this anomaly. Exercise-induced IV dysfunction may be the! first manifestation of cardiac involvement in patients with diabetes. Increasing the supply of amino acids in addition to conventional therapy significantly attenuates this phenomenon. Although the precise underlying pathophysiologic mechanism is not completely known, these observations may eventually be important in designing an optimal dietary or supplemental approach for patients with diabetes in order to prevent progressive myocardial dysfunction. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:17A / 20A
页数:4
相关论文
共 37 条
  • [21] IMPAIRED LEFT-VENTRICULAR SYSTOLIC FUNCTION DURING EXERCISE IN MIDDLE-AGED INSULIN-DEPENDENT AND NONINSULIN-DEPENDENT DIABETIC SUBJECTS WITHOUT CLINICALLY EVIDENT CARDIOVASCULAR-DISEASE
    MUSTONEN, JN
    UUSITUPA, MIJ
    TAHVANAINEN, K
    TALWAR, S
    LAAKSO, M
    LANSIMIES, E
    KUIKKA, JT
    PYORALA, K
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (17) : 1273 - 1279
  • [22] PROTEIN-METABOLISM IN SKELETAL-MUSCLE, DIAPHRAGM, AND HEART OF DIABETIC RATS
    PAIN, VM
    ALBERTSE, EC
    GARLICK, PJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (06): : E604 - E610
  • [23] THE EFFECT OF DIABETES ON PERFORMANCE AND METABOLISM OF RAT HEARTS
    PENPARGKUL, S
    SCHAIBLE, T
    YIPINTSOI, T
    SCHEUER, J
    [J]. CIRCULATION RESEARCH, 1980, 47 (06) : 911 - 921
  • [24] CARDIAC MYOFIBRILLAR ATPASE ACTIVITY IN DIABETIC RATS
    PIERCE, GN
    DHALLA, NS
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1981, 13 (12) : 1063 - 1069
  • [25] Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
    Pitt, B
    Segal, R
    Martinez, FA
    Meurers, G
    Cowley, AJ
    Thomas, I
    Deedwania, PC
    Ney, DE
    Snavely, DB
    Chang, PI
    [J]. LANCET, 1997, 349 (9054) : 747 - 752
  • [26] Interaction between glutamine availability and metabolism of glycogen, tricarboxylic acid cycle intermediates and glutathione
    Rennie, MJ
    Bowtell, JL
    Bruce, M
    Khogali, SEO
    [J]. JOURNAL OF NUTRITION, 2001, 131 (09) : 2488S - 2490S
  • [27] MYOCARDIAL DYSFUNCTION AND ABNORMAL LEFT-VENTRICULAR EXERCISE RESPONSE IN AUTONOMIC DIABETIC-PATIENTS
    SCOGNAMIGLIO, R
    FASOLI, G
    FERRI, M
    NISTRI, S
    MIORELLI, M
    EGLOFF, C
    BUJA, G
    FEDELE, D
    DALLAVOLTA, S
    [J]. CLINICAL CARDIOLOGY, 1995, 18 (05) : 276 - 282
  • [28] Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes
    Scognamiglio, R
    Avogaro, A
    de Kreutzenberg, SV
    Negut, C
    Palisi, M
    Bagolin, E
    Tiengo, A
    [J]. DIABETES, 2002, 51 (03) : 808 - 812
  • [29] Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus
    Scognamiglio, R
    Avogaro, A
    Casara, D
    Crepaldi, C
    Marin, M
    Palisi, M
    Mingardi, R
    Erle, G
    Fasoli, G
    Dalla Volta, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 404 - 412
  • [30] L-Arginine protects human heart cells from low-volume anoxia and reoxygenation
    Shiono, N
    Rao, V
    Weisel, RD
    Kawasaki, M
    Li, RK
    Mickle, DAG
    Fedak, PWM
    Tumiati, LC
    Ko, L
    Verma, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (03): : H805 - H815